MIR4435-2HG Gene

Name MIR4435-2 host gene
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMIR4435‐2HG is a long non‑coding RNA that is consistently overexpressed in a wide variety of human cancers and is closely associated with advanced stage, metastasis and poor clinical prognosis. Its upregulation has been reported in lung, ovarian, gastric, prostate and several other carcinomas where it modulates major oncogenic signaling pathways—including Wnt/β‑catenin, TGF‑β, PI3K/AKT, MDM2/p53, Hippo and MAPK/ERK—to promote cell proliferation, migration, invasion, epithelial–mesenchymal transition (EMT) and the maintenance of cancer stem cell traits."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nA common mechanistic theme is that MIR4435‑2HG functions as a competitive endogenous RNA (ceRNA), sequestering specific microRNAs and thereby derepressing their target messenger RNAs. For example, in oral squamous cell carcinoma it sponges miR‑296‑5p to modulate Akt2‐mediated upregulation of the EMT transcription factor SNAI1; in glioma it acts as a sponge for miR‑125a‑5p and miR‑125b‑5p to enhance CD44 expression; in glioblastoma cells it binds and downregulates miR‑1224‑5p to promote TGF‑β receptor 2 (TGFBR2) expression; in head and neck squamous cell carcinoma it interacts with miR‑383‑5p to upregulate RBM3; and in liver cancer, its interaction with miR‑136‑5p leads to increased expression of B3GNT5."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "13"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn several tumor models, MIR4435‑2HG also promotes EMT and metastatic behavior by positively regulating TGF‑β signaling. In oral squamous cell carcinoma, for instance, its overexpression is associated with increased levels of TGF‑β1 and enhanced cell migration, proliferation and invasion—a process that can be interrupted by TGF‑β inhibitors."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}, {"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its role as a ceRNA and signal modulator, unique structural features of MIR4435‑2HG appear critical for its function. A nearly identical hairpin structure—also found in its homolog LINC00152—has been shown to be essential for promoting cellular invasion. Moreover, MIR4435‑2HG can influence cellular metabolism and immune responses; for example, in primary myeloid dendritic cells from HIV‑1 elite controllers, its upregulation is linked to enhanced immunometabolic activity via epigenetic modification of the mTORC1 component RPTOR, while in fumarate hydratase–deficient renal cell carcinoma it is induced by fumarate, binds to STAT1 and activates glutaminase (GLS1) to reprogram tumor metabolism."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFinally, the expression of MIR4435‑2HG has emerged as an important biomarker not only for tumor aggressiveness across malignancies such as colorectal, bladder, melanoma and head and neck cancers but also in non‑malignant conditions. Its differential expression in pre‑malignant colon polyps, osteoarthritis and in exosomes derived from M2‑polarized macrophages in infantile hemangiomas underscores its potential utility for early diagnosis, prognostication and as a predictor of therapeutic response (for example, in Bacillus Calmette–Guérin–treated non‑muscle invasive bladder cancer)."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Haiyun Qian, Li Chen, Jiangping Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The lncRNA MIR4435-2HG promotes lung cancer progression by activating β-catenin signalling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Med (Berl) (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00109-018-1654-5"}], "href": "https://doi.org/10.1007/s00109-018-1654-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29872866"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29872866"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Brian J Reon, Bruno Takao Real Karia, Manjari Kiran, et al. "}, {"type": "b", "children": [{"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "LINC00152"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " Promotes Invasion through a 3'-Hairpin Structure and Associates with Prognosis in Glioblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-18-0322"}], "href": "https://doi.org/10.1158/1541-7786.MCR-18-0322"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29991527"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29991527"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Jianming Gong, Xiaoyang Xu, Xuanli Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MIR4435-2HG is a potential early diagnostic marker for ovarian carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Biochim Biophys Sin (Shanghai) (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/abbs/gmz085"}], "href": "https://doi.org/10.1093/abbs/gmz085"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31435668"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31435668"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Haiyong Wang, Mengjie Wu, Yimin Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.102164"}], "href": "https://doi.org/10.18632/aging.102164"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31484163"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31484163"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Mei Yang, Xiaohua He, Xiaoxian Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MIR4435-2HG-mediated upregulation of TGF-β1 promotes migration and proliferation of nonsmall cell lung cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Environ Toxicol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/tox.22893"}], "href": "https://doi.org/10.1002/tox.22893"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31875359"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31875359"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Pengyi Xing, Ye Wang, Li Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Knockdown of lncRNA MIR4435‑2HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "in vitro"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " and "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "in vivo"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " by blocking the activation of the FAK/AKT/β‑catenin signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2021.4926"}], "href": "https://doi.org/10.3892/ijmm.2021.4926"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33846784"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33846784"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Fangnan Zhao, Yuling Liu, Fangshun Tan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MIR4435-2HG: A Tumor-associated Long Non-coding RNA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Pharm Des (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/1381612828666220607100228"}], "href": "https://doi.org/10.2174/1381612828666220607100228"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35674305"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35674305"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Chenming Zhong, Zijun Xie, Ling-Hui Zeng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Immunol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fimmu.2022.855078"}], "href": "https://doi.org/10.3389/fimmu.2022.855078"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35784328"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35784328"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Zhijin Li, Hua Tan, Weiling Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Integrative analysis of DNA methylation and gene expression profiles identifies MIR4435-2HG as an oncogenic lncRNA for glioma progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2019.144012"}], "href": "https://doi.org/10.1016/j.gene.2019.144012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31357021"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31357021"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Shuwei Zhang, Chen Li, Junchao Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/febs.15233"}], "href": "https://doi.org/10.1111/febs.15233"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31997506"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31997506"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Hongchao Xu, Beilin Zhang, Yinggui Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.15280"}], "href": "https://doi.org/10.1111/jcmm.15280"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32319715"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32319715"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Shu Wang, Xianfeng Chen, Tiankui Qiao "}, {"type": "b", "children": [{"type": "t", "text": "Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2021.8050"}], "href": "https://doi.org/10.3892/or.2021.8050"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33846802"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33846802"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Yungang Zhu, Baoguo Li, Guoping Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "lncRNA MIR4435‑2HG promotes the progression of liver cancer by upregulating B3GNT5 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2021.12554"}], "href": "https://doi.org/10.3892/mmr.2021.12554"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34859256"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34859256"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Huan Shen, Bin Sun, Yongjin Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MIR4435-2HG regulates cancer cell behaviors in oral squamous cell carcinoma cell growth by upregulating TGF-β1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Odontology (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10266-020-00488-x"}], "href": "https://doi.org/10.1007/s10266-020-00488-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32016787"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32016787"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Ciputra Adijaya Hartana, Yelizaveta Rassadkina, Ce Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA MIR4435-2HG enhances metabolic function of myeloid dendritic cells from HIV-1 elite controllers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI146136"}], "href": "https://doi.org/10.1172/JCI146136"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33938445"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33938445"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Liangsong Zhu, Yilun Hong, Ziran Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fumarate induces LncRNA-MIR4435-2HG to regulate glutamine metabolism remodeling and promote the development of FH-deficient renal cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-024-06510-2"}], "href": "https://doi.org/10.1038/s41419-024-06510-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38374146"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38374146"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Yu Xiao, Yucheng Bao, Liang Tang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MIR4435-2HG is downregulated in osteoarthritis and regulates chondrocyte cell proliferation and apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Orthop Surg Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13018-019-1278-7"}], "href": "https://doi.org/10.1186/s13018-019-1278-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31387631"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31387631"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "M-Y Shen, G-R Zhou, Z -Y Zhang "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MIR4435-2HG contributes into colorectal cancer development and predicts poor prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202002_20354"}], "href": "https://doi.org/10.26355/eurrev_202002_20354"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32141545"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32141545"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "D-M Ma, D Sun, J Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA MIR4435-2HG recruits miR-802 from FLOT2 to promote melanoma progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202003_20530"}], "href": "https://doi.org/10.26355/eurrev_202003_20530"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32196611"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32196611"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Danrong Zhu, Piao Guo, Xin Yu Jin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long-chain Non-coding RNA MIR4435-2HG Expression Correlates With Size of Intestinal Polyps in Children and With Metastasis of Colon Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Anticancer Res (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.21873/anticanres.15975"}], "href": "https://doi.org/10.21873/anticanres.15975"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36191994"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36191994"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Lu Pei, Dong Yan, Qingqing He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Oncol (Dordr) (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13402-023-00826-5"}], "href": "https://doi.org/10.1007/s13402-023-00826-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37355516"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37355516"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Zhiyu Li, Zhongying Cao, Nanxi Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "M2 Macrophage-Derived Exosomal lncRNA MIR4435-2HG Promotes Progression of Infantile Hemangiomas by Targeting HNRNPA1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Nanomedicine (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2147/IJN.S435132"}], "href": "https://doi.org/10.2147/IJN.S435132"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37881607"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37881607"}]}]}]}
Synonyms MORRBID, AGD2, MIR4435-1HG, LINC00978, AK001796, lncRNA-AWPPH
NCBI Gene ID 541471
API
Download Associations
Predicted Functions View MIR4435-2HG's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR4435-2HG's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR4435-2HG's ARCHS4 Predicted Functions.

Functional Associations

MIR4435-2HG has 956 functional associations with biological entities spanning 3 categories (disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 14 datasets.

Click the + buttons to view associations for MIR4435-2HG from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of MIR4435-2HG gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of MIR4435-2HG gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of MIR4435-2HG gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR4435-2HG gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CellMarker Gene-Cell Type Associations cell types associated with MIR4435-2HG gene from the CellMarker Gene-Cell Type Associations dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of MIR4435-2HG gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of MIR4435-2HG gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of MIR4435-2HG gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of MIR4435-2HG gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
HuBMAP Azimuth Cell Type Annotations cell types associated with MIR4435-2HG gene from the HuBMAP Azimuth Cell Type Annotations dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with MIR4435-2HG gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR4435-2HG gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of MIR4435-2HG gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by MIR4435-2HG gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.